ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

6.26%

$5.60

Market Cap $86.68M

Healthcare Medical Devices

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

AVR	Trading Halt	PRICE SENSITIVE	23/10/23	613.94KB	Share
AVR	Anteris Completes DurAVR THV EFS Enrolment	PRICE SENSITIVE	17/10/23	232.36KB	Share
AVR	R&D Refund		13/10/23	224.67KB	Share
AVR	Notification of cessation of securities - AVR		06/10/23	23.11KB	Share
AVR	Cleansing Notice		29/09/23	220.39KB	Share
AVR	Application for quotation of securities - AVR		29/09/23	26.93KB	Share
AVR	Change of Director's Interest Notice x 4		20/09/23	296.46KB	Share
AVR	Notification regarding unquoted securities - AVR		19/09/23	30.53KB	Share
AVR	Anteris to Present at Cantor Healthcare Conference		12/09/23	206.94KB	Share
AVR	Results of Meeting		06/09/23	403.79KB	Share
AVR	Cleansing Notice		04/09/23	221.27KB	Share
AVR	Application for quotation of securities - AVR		01/09/23	26.95KB	Share
AVR	Appendix 4D and Half Year Financial Report Announcement	PRICE SENSITIVE	25/08/23	182.9KB	Share
AVR	Appendix 4D and Half Year Financial Report	PRICE SENSITIVE	25/08/23	714.97KB	Share
AVR	Cleansing Notice		18/08/23	159.93KB	Share
AVR	Application for quotation of securities - AVR		18/08/23	26.94KB	Share
AVR	Exceptional Results in Second Valve-in-Valve Case	PRICE SENSITIVE	14/08/23	145.89KB	Share
AVR	Notification of cessation of securities - AVR		09/08/23	23.05KB	Share
AVR	Notification regarding unquoted securities - AVR		09/08/23	29.62KB	Share
AVR	Commencement of American Depository Receipt Program	PRICE SENSITIVE	09/08/23	164.44KB	Share
AVR	Montefiore enrolls Patients in US Early Feasibility Study	PRICE SENSITIVE	09/08/23	208.28KB	Share
AVR	Notice of Extraordinary General Meeting/Proxy Form		07/08/23	703.33KB	Share
AVR	DurAVR first successful implantation Valve-in-Valve	PRICE SENSITIVE	31/07/23	155.23KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	28/07/23	305.43KB	Share
AVR	Notification of cessation of securities - AVR		20/07/23	23KB	Share
AVR	Cleansing Notice		13/07/23	161.22KB	Share
AVR	Application for quotation of securities - AVR		13/07/23	29.6KB	Share
AVR	Cleansing Notice		29/06/23	161.16KB	Share
AVR	Application for quotation of securities - AVR		29/06/23	26.94KB	Share
AVR	Cleansing Notice		22/06/23	160.58KB	Share
AVR	Application for quotation of securities - AVR		22/06/23	26.94KB	Share
AVR	Ceasing to be a substantial holder from MUFG		19/06/23	730.85KB	Share
AVR	Ceasing to be a substantial holder from MS		16/06/23	218.64KB	Share
AVR	Becoming a substantial holder from MUFG		16/06/23	567.72KB	Share
AVR	Becoming a substantial holder from MS		16/06/23	424.65KB	Share
AVR	Ceasing to be a substantial holder from MUFG		14/06/23	1.24MB	Share
AVR	Ceasing to be a substantial holder from MS		14/06/23	218.38KB	Share
AVR	Latest Patient Group Show Best Results to Date at 30 Days	PRICE SENSITIVE	13/06/23	177.4KB	Share
AVR	Becoming a substantial holder from MUFG		09/06/23	866.65KB	Share
AVR	DurAVR THV Demonstrate Sustained Haemodynamics to 1 Year	PRICE SENSITIVE	09/06/23	177.46KB	Share
AVR	Becoming a substantial holder from MS		09/06/23	434.33KB	Share
AVR	Ceasing to be a substantial holder from MUFG		07/06/23	808.41KB	Share
AVR	Ceasing to be a substantial holder from MS		07/06/23	278.1KB	Share
AVR	Becoming a substantial holder from MUFG		06/06/23	816.76KB	Share
AVR	Becoming a substantial holder from MS		06/06/23	435.06KB	Share
AVR	Ceasing to be a substantial holder from MUFG		01/06/23	739.42KB	Share
AVR	Notification regarding unquoted securities - AVR		01/06/23	29.55KB	Share
AVR	Change of Director's Interest Notice		01/06/23	195KB	Share
AVR	Notification regarding unquoted securities - AVR		01/06/23	30.08KB	Share
AVR	Application for quotation of securities - AVR		01/06/23	27.15KB	Share
AVR	Ceasing to be a substantial holder from MS		31/05/23	228.14KB	Share
AVR	DurAVR Maintains Exceptional Results in New Patient Cohort	PRICE SENSITIVE	31/05/23	151.62KB	Share
AVR	Becoming a substantial holder from MUFG		30/05/23	393.61KB	Share
AVR	Notification of cessation of securities - AVR		30/05/23	25.13KB	Share
AVR	Becoming a substantial holder from MS		30/05/23	434.39KB	Share
AVR	Results of Annual General Meeting		29/05/23	312.76KB	Share
AVR	AGM Chairman Address and CEO Presentation	PRICE SENSITIVE	29/05/23	8MB	Share
AVR	Notice of Annual General Meeting Withdrawal of Resolutions		29/05/23	190.45KB	Share
AVR	Ceasing to be a substantial holder from MUFG		22/05/23	753.59KB	Share
AVR	FIH Results Presented at EuroPCR & Simultaneous Publication	PRICE SENSITIVE	22/05/23	171.97KB	Share
AVR	Ceasing to be a substantial holder from MS		19/05/23	211.01KB	Share
AVR	Becoming a substantial holder from MUFG		19/05/23	825.8KB	Share
AVR	Becoming a substantial holder from MS		19/05/23	427.78KB	Share
AVR	Ceasing to be a substantial holder from MUFG		18/05/23	249.48KB	Share
AVR	Ceasing to be a substantial holder from MS		18/05/23	242.13KB	Share
AVR	Additional Patent for Heart Valve Replacement Technology	PRICE SENSITIVE	17/05/23	189.9KB	Share
AVR	Becoming a substantial holder from MUFG		12/05/23	884.25KB	Share
AVR	Becoming a substantial holder from MS		12/05/23	455.84KB	Share
AVR	Ceasing to be a substantial holder from MUFG		11/05/23	1.14MB	Share
AVR	Ceasing to be a substantial holder from MS		11/05/23	267.21KB	Share
AVR	Cleansing Notice		05/05/23	160.35KB	Share
AVR	Application for quotation of securities - AVR		05/05/23	29.53KB	Share
AVR	Notice of Annual General Meeting/Proxy Form		28/04/23	800.77KB	Share
AVR	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	24/04/23	285.17KB	Share
AVR	Application for quotation of securities - AVR		20/04/23	27.07KB	Share
AVR	Cleansing Notice		20/04/23	160.58KB	Share
AVR	Application for quotation of securities - AVR		20/04/23	36.05KB	Share
AVR	Agreement to Develop New Heart Valve Repair Device	PRICE SENSITIVE	19/04/23	233.95KB	Share
AVR	Corporate Governance Statement and Appendix 4G		14/04/23	1.61MB	Share
AVR	Annual Report to shareholders		14/04/23	3.17MB	Share
AVR	Patent for Transcatheter Heart Valve Replacement Technology	PRICE SENSITIVE	12/04/23	142.14KB	Share
AVR	Becoming a substantial holder from MUFG		12/04/23	916.92KB	Share
AVR	Ceasing to be a substantial holder from MUFG		11/04/23	865.46KB	Share
AVR	Becoming a substantial holder for MS		11/04/23	609.2KB	Share
AVR	Ceasing to be a substantial holder from MS		11/04/23	432.22KB	Share
AVR	Becoming a substantial holder from MUFG		04/04/23	801.28KB	Share
AVR	Becoming a substantial holder from MS		04/04/23	639.92KB	Share
AVR	Becoming a substantial holder		03/04/23	532.69KB	Share
AVR	FDA Allows Manufacturing to Begin at Expanded Facility		27/03/23	168.58KB	Share
AVR	Presentation at NWR Virtual Healthcare Conference	PRICE SENSITIVE	21/03/23	3.68MB	Share
AVR	Application for quotation of securities - AVR		20/03/23	29.76KB	Share
AVR	NWR Virtual Healthcare Conference		20/03/23	168.37KB	Share
AVR	Notice of AGM Date and Closing of Nominations for Directors		20/03/23	139.38KB	Share
AVR	S&P DJI Announces March 2023 Quarterly Rebalance	PRICE SENSITIVE	03/03/23	128.97KB	Share
AVR	Preliminary Final Report	PRICE SENSITIVE	28/02/23	1.98MB	Share
AVR	Notification of cessation of securities - AVR		27/02/23	23.01KB	Share
AVR	Cleansing Notice		15/02/23	160.37KB	Share
AVR	Notification regarding unquoted securities - AVR		15/02/23	27.56KB	Share
AVR	Application for quotation of securities - AVR		15/02/23	27.07KB	Share
AVR	Settlement of $35M Capital Raising Transaction	PRICE SENSITIVE	15/02/23	197.59KB	Share

AVR Trading Halt
23/10/23	PRICE SENSITIVE	613.94KB	Share
AVR Anteris Completes DurAVR THV EFS Enrolment
17/10/23	PRICE SENSITIVE	232.36KB	Share
AVR R&D Refund
13/10/23		224.67KB	Share
AVR Notification of cessation of securities - AVR
06/10/23		23.11KB	Share
AVR Cleansing Notice
29/09/23		220.39KB	Share
AVR Application for quotation of securities - AVR
29/09/23		26.93KB	Share
AVR Change of Director's Interest Notice x 4
20/09/23		296.46KB	Share
AVR Notification regarding unquoted securities - AVR
19/09/23		30.53KB	Share
AVR Anteris to Present at Cantor Healthcare Conference
12/09/23		206.94KB	Share
AVR Results of Meeting
06/09/23		403.79KB	Share
AVR Cleansing Notice
04/09/23		221.27KB	Share
AVR Application for quotation of securities - AVR
01/09/23		26.95KB	Share
AVR Appendix 4D and Half Year Financial Report Announcement
25/08/23	PRICE SENSITIVE	182.9KB	Share
AVR Appendix 4D and Half Year Financial Report
25/08/23	PRICE SENSITIVE	714.97KB	Share
AVR Cleansing Notice
18/08/23		159.93KB	Share
AVR Application for quotation of securities - AVR
18/08/23		26.94KB	Share
AVR Exceptional Results in Second Valve-in-Valve Case
14/08/23	PRICE SENSITIVE	145.89KB	Share
AVR Notification of cessation of securities - AVR
09/08/23		23.05KB	Share
AVR Notification regarding unquoted securities - AVR
09/08/23		29.62KB	Share
AVR Commencement of American Depository Receipt Program
09/08/23	PRICE SENSITIVE	164.44KB	Share
AVR Montefiore enrolls Patients in US Early Feasibility Study
09/08/23	PRICE SENSITIVE	208.28KB	Share
AVR Notice of Extraordinary General Meeting/Proxy Form
07/08/23		703.33KB	Share
AVR DurAVR first successful implantation Valve-in-Valve
31/07/23	PRICE SENSITIVE	155.23KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
28/07/23	PRICE SENSITIVE	305.43KB	Share
AVR Notification of cessation of securities - AVR
20/07/23		23KB	Share
AVR Cleansing Notice
13/07/23		161.22KB	Share
AVR Application for quotation of securities - AVR
13/07/23		29.6KB	Share
AVR Cleansing Notice
29/06/23		161.16KB	Share
AVR Application for quotation of securities - AVR
29/06/23		26.94KB	Share
AVR Cleansing Notice
22/06/23		160.58KB	Share
AVR Application for quotation of securities - AVR
22/06/23		26.94KB	Share
AVR Ceasing to be a substantial holder from MUFG
19/06/23		730.85KB	Share
AVR Ceasing to be a substantial holder from MS
16/06/23		218.64KB	Share
AVR Becoming a substantial holder from MUFG
16/06/23		567.72KB	Share
AVR Becoming a substantial holder from MS
16/06/23		424.65KB	Share
AVR Ceasing to be a substantial holder from MUFG
14/06/23		1.24MB	Share
AVR Ceasing to be a substantial holder from MS
14/06/23		218.38KB	Share
AVR Latest Patient Group Show Best Results to Date at 30 Days
13/06/23	PRICE SENSITIVE	177.4KB	Share
AVR Becoming a substantial holder from MUFG
09/06/23		866.65KB	Share
AVR DurAVR THV Demonstrate Sustained Haemodynamics to 1 Year
09/06/23	PRICE SENSITIVE	177.46KB	Share
AVR Becoming a substantial holder from MS
09/06/23		434.33KB	Share
AVR Ceasing to be a substantial holder from MUFG
07/06/23		808.41KB	Share
AVR Ceasing to be a substantial holder from MS
07/06/23		278.1KB	Share
AVR Becoming a substantial holder from MUFG
06/06/23		816.76KB	Share
AVR Becoming a substantial holder from MS
06/06/23		435.06KB	Share
AVR Ceasing to be a substantial holder from MUFG
01/06/23		739.42KB	Share
AVR Notification regarding unquoted securities - AVR
01/06/23		29.55KB	Share
AVR Change of Director's Interest Notice
01/06/23		195KB	Share
AVR Notification regarding unquoted securities - AVR
01/06/23		30.08KB	Share
AVR Application for quotation of securities - AVR
01/06/23		27.15KB	Share
AVR Ceasing to be a substantial holder from MS
31/05/23		228.14KB	Share
AVR DurAVR Maintains Exceptional Results in New Patient Cohort
31/05/23	PRICE SENSITIVE	151.62KB	Share
AVR Becoming a substantial holder from MUFG
30/05/23		393.61KB	Share
AVR Notification of cessation of securities - AVR
30/05/23		25.13KB	Share
AVR Becoming a substantial holder from MS
30/05/23		434.39KB	Share
AVR Results of Annual General Meeting
29/05/23		312.76KB	Share
AVR AGM Chairman Address and CEO Presentation
29/05/23	PRICE SENSITIVE	8MB	Share
AVR Notice of Annual General Meeting Withdrawal of Resolutions
29/05/23		190.45KB	Share
AVR Ceasing to be a substantial holder from MUFG
22/05/23		753.59KB	Share
AVR FIH Results Presented at EuroPCR & Simultaneous Publication
22/05/23	PRICE SENSITIVE	171.97KB	Share
AVR Ceasing to be a substantial holder from MS
19/05/23		211.01KB	Share
AVR Becoming a substantial holder from MUFG
19/05/23		825.8KB	Share
AVR Becoming a substantial holder from MS
19/05/23		427.78KB	Share
AVR Ceasing to be a substantial holder from MUFG
18/05/23		249.48KB	Share
AVR Ceasing to be a substantial holder from MS
18/05/23		242.13KB	Share
AVR Additional Patent for Heart Valve Replacement Technology
17/05/23	PRICE SENSITIVE	189.9KB	Share
AVR Becoming a substantial holder from MUFG
12/05/23		884.25KB	Share
AVR Becoming a substantial holder from MS
12/05/23		455.84KB	Share
AVR Ceasing to be a substantial holder from MUFG
11/05/23		1.14MB	Share
AVR Ceasing to be a substantial holder from MS
11/05/23		267.21KB	Share
AVR Cleansing Notice
05/05/23		160.35KB	Share
AVR Application for quotation of securities - AVR
05/05/23		29.53KB	Share
AVR Notice of Annual General Meeting/Proxy Form
28/04/23		800.77KB	Share
AVR Quarterly Activities/Appendix 4C Cash Flow Report
24/04/23	PRICE SENSITIVE	285.17KB	Share
AVR Application for quotation of securities - AVR
20/04/23		27.07KB	Share
AVR Cleansing Notice
20/04/23		160.58KB	Share
AVR Application for quotation of securities - AVR
20/04/23		36.05KB	Share
AVR Agreement to Develop New Heart Valve Repair Device
19/04/23	PRICE SENSITIVE	233.95KB	Share
AVR Corporate Governance Statement and Appendix 4G
14/04/23		1.61MB	Share
AVR Annual Report to shareholders
14/04/23		3.17MB	Share
AVR Patent for Transcatheter Heart Valve Replacement Technology
12/04/23	PRICE SENSITIVE	142.14KB	Share
AVR Becoming a substantial holder from MUFG
12/04/23		916.92KB	Share
AVR Ceasing to be a substantial holder from MUFG
11/04/23		865.46KB	Share
AVR Becoming a substantial holder for MS
11/04/23		609.2KB	Share
AVR Ceasing to be a substantial holder from MS
11/04/23		432.22KB	Share
AVR Becoming a substantial holder from MUFG
04/04/23		801.28KB	Share
AVR Becoming a substantial holder from MS
04/04/23		639.92KB	Share
AVR Becoming a substantial holder
03/04/23		532.69KB	Share
AVR FDA Allows Manufacturing to Begin at Expanded Facility
27/03/23		168.58KB	Share
AVR Presentation at NWR Virtual Healthcare Conference
21/03/23	PRICE SENSITIVE	3.68MB	Share
AVR Application for quotation of securities - AVR
20/03/23		29.76KB	Share
AVR NWR Virtual Healthcare Conference
20/03/23		168.37KB	Share
AVR Notice of AGM Date and Closing of Nominations for Directors
20/03/23		139.38KB	Share
AVR S&P DJI Announces March 2023 Quarterly Rebalance
03/03/23	PRICE SENSITIVE	128.97KB	Share
AVR Preliminary Final Report
28/02/23	PRICE SENSITIVE	1.98MB	Share
AVR Notification of cessation of securities - AVR
27/02/23		23.01KB	Share
AVR Cleansing Notice
15/02/23		160.37KB	Share
AVR Notification regarding unquoted securities - AVR
15/02/23		27.56KB	Share
AVR Application for quotation of securities - AVR
15/02/23		27.07KB	Share
AVR Settlement of $35M Capital Raising Transaction
15/02/23	PRICE SENSITIVE	197.59KB	Share

REFRESH

First 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $5.60		Change 0.330(6.26%)		Mkt cap ! $86.68M

Open	High	Low	Value	Volume
$5.50	$5.60	$5.30	$89.45K	16.14K

Buyers (Bids)

No.	Vol.	Price($)
1	103	$5.30

Sellers (Offers)

Price($)	Vol.	No.
$5.98	992	1

View Market Depth

No.	Vol.	Price($)
1	103	5.300
1	920	5.270
1	613	5.240
1	576	5.200
1	20000	5.150

Price($)	Vol.	No.
5.980	992	1
5.990	3500	1
6.000	3719	2
6.050	20000	1
6.500	230	2

Last trade - 15.29pm 22/08/2025 (20 minute delay)


Last $5.59		Change 0.330 ( 4.68 %)
Open	High	Low	Volume
$5.59	$5.59	$5.29	3526
Last updated 15.28pm 22/08/2025 ?

AVR (ASX) Chart

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate Spotlight
Not Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

ANTERIS TECHNOLOGIES GLOBAL CORP. - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

EV Resources executes strategic MOU with Wogen, XCLR to fund and advance Los Lirios antimony project

Top Stories

Corporate Spotlight
Not Yet Available